Insights About Striatal Circuit Function and Schizophrenia From a Mouse Model of Dopamine D2 Receptor Upregulation.

PubWeight™: 0.75‹?›

🔗 View Article (PMID 27720388)

Published in Biol Psychiatry on July 14, 2016

Authors

Eleanor H Simpson1, Christoph Kellendonk2

Author Affiliations

1: Departments of Psychiatry, Columbia University, New York, New York; Center for Neurobiology and Behavior, New York State Psychiatric Institute, New York, New York. Electronic address: Es534@columbia.edu.
2: Pharmacology, Columbia University, New York, New York; Division of Molecular Therapeutics (CK), New York State Psychiatric Institute, New York, New York.

Articles cited by this

(truncated to the top 100)

Relative and absolute strength of response as a function of frequency of reinforcement. J Exp Anal Behav (1961) 101.16

The functional anatomy of basal ganglia disorders. Trends Neurosci (1989) 12.28

What are the functional consequences of neurocognitive deficits in schizophrenia? Am J Psychiatry (1996) 11.03

Neurocognitive deficits and functional outcome in schizophrenia: are we measuring the "right stuff"? Schizophr Bull (2000) 9.62

Progressive ratio as a measure of reward strength. Science (1961) 6.57

Modulation of striatal projection systems by dopamine. Annu Rev Neurosci (2011) 4.84

Physiologic dysfunction of dorsolateral prefrontal cortex in schizophrenia. I. Regional cerebral blood flow evidence. Arch Gen Psychiatry (1986) 4.34

Dopamine receptor binding predicts clinical and pharmacological potencies of antischizophrenic drugs. Science (1976) 4.07

Transient and selective overexpression of dopamine D2 receptors in the striatum causes persistent abnormalities in prefrontal cortex functioning. Neuron (2006) 4.03

Reward-related cortical inputs define a large striatal region in primates that interface with associative cortical connections, providing a substrate for incentive-based learning. J Neurosci (2006) 3.87

Anhedonia in schizophrenia: distinctions between anticipatory and consummatory pleasure. Schizophr Res (2007) 3.79

Elevated striatal dopamine function linked to prodromal signs of schizophrenia. Arch Gen Psychiatry (2009) 3.67

Distinct roles for direct and indirect pathway striatal neurons in reinforcement. Nat Neurosci (2012) 3.40

Increased baseline occupancy of D2 receptors by dopamine in schizophrenia. Proc Natl Acad Sci U S A (2000) 3.34

Disruption of NMDAR-dependent burst firing by dopamine neurons provides selective assessment of phasic dopamine-dependent behavior. Proc Natl Acad Sci U S A (2009) 3.15

Prestimulus effects on human startle reflex in normals and schizophrenics. Psychophysiology (1978) 3.08

Schizophrenics show spatial working memory deficits. Arch Gen Psychiatry (1992) 3.02

Spine pruning drives antipsychotic-sensitive locomotion via circuit control of striatal dopamine. Nat Neurosci (2015) 2.89

Antipsychotic drug doses and neuroleptic/dopamine receptors. Nature (1976) 2.85

Supranormal stimulation of D1 dopamine receptors in the rodent prefrontal cortex impairs spatial working memory performance. J Neurosci (1997) 2.43

The nature of dopamine dysfunction in schizophrenia and what this means for treatment. Arch Gen Psychiatry (2012) 2.34

Reduced prefrontal activity predicts exaggerated striatal dopaminergic function in schizophrenia. Nat Neurosci (2002) 2.32

Measuring hedonic impact in animals and infants: microstructure of affective taste reactivity patterns. Neurosci Biobehav Rev (2000) 2.29

Increased synaptic dopamine function in associative regions of the striatum in schizophrenia. Arch Gen Psychiatry (2010) 2.19

A high-throughput screening procedure for identifying mice with aberrant taste and oromotor function. Chem Senses (2002) 2.01

Neuromodulation of thought: flexibilities and vulnerabilities in prefrontal cortical network synapses. Neuron (2012) 1.99

Projection subtypes of rat neostriatal matrix cells revealed by intracellular injection of biocytin. J Neurosci (1990) 1.96

Effect of bitopertin, a glycine reuptake inhibitor, on negative symptoms of schizophrenia: a randomized, double-blind, proof-of-concept study. JAMA Psychiatry (2014) 1.81

Negative symptoms of schizophrenia are associated with abnormal effort-cost computations. Biol Psychiatry (2013) 1.77

Presynaptic striatal dopamine dysfunction in people at ultra-high risk for psychosis: findings in a second cohort. Biol Psychiatry (2013) 1.76

Physiological dysfunction of dorsolateral prefrontal cortex in schizophrenia. III. A new cohort and evidence for a monoaminergic mechanism. Arch Gen Psychiatry (1988) 1.75

Pharmacological treatment of schizophrenia: a critical review of the pharmacology and clinical effects of current and future therapeutic agents. Mol Psychiatry (2012) 1.73

6-Hydroxydopamine lesions of the prefrontal cortex in monkeys enhance performance on an analog of the Wisconsin Card Sort Test: possible interactions with subcortical dopamine. J Neurosci (1994) 1.70

The construct of attention in schizophrenia. Biol Psychiatry (2008) 1.68

From perception to functional outcome in schizophrenia: modeling the role of ability and motivation. Arch Gen Psychiatry (2012) 1.68

Transient overexpression of striatal D2 receptors impairs operant motivation and interval timing. J Neurosci (2007) 1.66

Haloperidol and nucleus accumbens dopamine depletion suppress lever pressing for food but increase free food consumption in a novel food choice procedure. Psychopharmacology (Berl) (1991) 1.65

The cognitive neuroscience of working memory: relevance to CNTRICS and schizophrenia. Biol Psychiatry (2008) 1.60

Striatal dopamine and working memory. Cereb Cortex (2008) 1.60

5-HT2A and 5-HT2C receptor antagonists have opposing effects on a measure of impulsivity: interactions with global 5-HT depletion. Psychopharmacology (Berl) (2004) 1.58

Decision-making impairments in the context of intact reward sensitivity in schizophrenia. Biol Psychiatry (2008) 1.55

Exclusive and common targets of neostriatofugal projections of rat striosome neurons: a single neuron-tracing study using a viral vector. Eur J Neurosci (2011) 1.55

A review of reward processing and motivational impairment in schizophrenia. Schizophr Bull (2013) 1.52

Imaging dopamine transmission in schizophrenia. A review and meta-analysis. Q J Nucl Med (1998) 1.52

Motivational deficits and cognitive test performance in schizophrenia. JAMA Psychiatry (2014) 1.50

Abnormal prefrontal activation directly related to pre-synaptic striatal dopamine dysfunction in people at clinical high risk for psychosis. Mol Psychiatry (2009) 1.46

Physiologic dysfunction of dorsolateral prefrontal cortex in schizophrenia. II. Role of neuroleptic treatment, attention, and mental effort. Arch Gen Psychiatry (1986) 1.42

Discrimination learning, reversal, and set-shifting in first-episode schizophrenia: stability over six years and specific associations with medication type and disorganization syndrome. Biol Psychiatry (2009) 1.41

Reduced capacity but spared precision and maintenance of working memory representations in schizophrenia. Arch Gen Psychiatry (2010) 1.37

Coding the direct/indirect pathways by D1 and D2 receptors is not valid for accumbens projections. Nat Neurosci (2015) 1.36

Dopamine scales performance in the absence of new learning. Neuron (2006) 1.35

Modeling cognitive endophenotypes of schizophrenia in mice. Trends Neurosci (2009) 1.32

Verbal working memory impairments in individuals with schizophrenia and their first-degree relatives: findings from the Consortium on the Genetics of Schizophrenia. Schizophr Res (2008) 1.29

Using conditional mutagenesis to study the brain. Biol Psychiatry (2003) 1.28

Executive functioning component mechanisms and schizophrenia. Biol Psychiatry (2008) 1.27

Dissociation of hedonic reaction to reward and incentive motivation in an animal model of the negative symptoms of schizophrenia. Neuropsychopharmacology (2012) 1.26

Measures of anhedonia and hedonic responses to sucrose in depressive and schizophrenic patients in comparison with healthy subjects. Eur Psychiatry (1998) 1.26

Development of social functioning in preschizophrenia children and adolescents: a systematic review. Psychol Bull (2008) 1.25

Effort, anhedonia, and function in schizophrenia: reduced effort allocation predicts amotivation and functional impairment. J Abnorm Psychol (2014) 1.25

Dopamine D2 receptors regulate the anatomical and functional balance of basal ganglia circuitry. Neuron (2014) 1.25

Genetically determined measures of striatal D2 signaling predict prefrontal activity during working memory performance. PLoS One (2010) 1.24

Prepulse inhibition in psychiatric disorders--apart from schizophrenia. J Psychiatr Res (2013) 1.22

Ratio and time requirements on operant schedules: effort-related effects of nucleus accumbens dopamine depletions. Eur J Neurosci (2005) 1.22

Opposing effects of 5-HT(2A) and 5-HT(2C) receptor antagonists in the rat and mouse on premature responding in the five-choice serial reaction time test. Psychopharmacology (Berl) (2007) 1.21

Temporal processing dysfunction in schizophrenia. Brain Cogn (2008) 1.19

Pharmacologic rescue of motivational deficit in an animal model of the negative symptoms of schizophrenia. Biol Psychiatry (2011) 1.16

Baseline and amphetamine-stimulated dopamine activity are related in drug-naïve schizophrenic subjects. Biol Psychiatry (2009) 1.15

Impaired timing precision produced by striatal D2 receptor overexpression is mediated by cognitive and motivational deficits. Behav Neurosci (2009) 1.14

The striatofugal fiber system in primates: a reevaluation of its organization based on single-axon tracing studies. Proc Natl Acad Sci U S A (2005) 1.13

Amotivation in schizophrenia: integrated assessment with behavioral, clinical, and imaging measures. Schizophr Bull (2014) 1.13

Early detection and intervention in schizophrenia: a new therapeutic model. JAMA (2013) 1.12

Transient and selective overexpression of D2 receptors in the striatum causes persistent deficits in conditional associative learning. Proc Natl Acad Sci U S A (2008) 1.10

Deficits in prefrontal cortical and extrastriatal dopamine release in schizophrenia: a positron emission tomographic functional magnetic resonance imaging study. JAMA Psychiatry (2015) 1.08

The organization of the striatal output system: a single-cell juxtacellular labeling study in the rat. Neurosci Res (2000) 1.08

Maintenance and manipulation of information in schizophrenia: further evidence for impairment in the central executive component of working memory. Schizophr Res (2004) 1.08

Acquiring and inhibiting prepotent responses in schizophrenia: event-related brain potentials and functional magnetic resonance imaging. Arch Gen Psychiatry (2004) 1.07

The puzzle box as a simple and efficient behavioral test for exploring impairments of general cognition and executive functions in mouse models of schizophrenia. Exp Neurol (2010) 1.03

Striatal D2 receptors regulate dendritic morphology of medium spiny neurons via Kir2 channels. J Neurosci (2012) 1.02

Impaired effort allocation in patients with schizophrenia. Schizophr Res (2014) 0.99

Effect of 6-hydroxydopamine lesions of the medial prefrontal cortex on neurotransmitter systems in subcortical sites in the rat. J Neurochem (1980) 0.99

Schizophrenia in translation: dissecting motivation in schizophrenia and rodents. Schizophr Bull (2012) 0.99

Effects of olanzapine, risperidone and haloperidol on prepulse inhibition in schizophrenia patients: a double-blind, randomized controlled trial. Schizophr Res (2007) 0.98

D2 receptor overexpression in the striatum leads to a deficit in inhibitory transmission and dopamine sensitivity in mouse prefrontal cortex. Proc Natl Acad Sci U S A (2011) 0.98

Timing dysfunctions in schizophrenia as measured by a repetitive finger tapping task. Brain Cogn (2009) 0.97

Correlations of striatal dopamine synthesis with default network deactivations during working memory in younger adults. Hum Brain Mapp (2010) 0.97

Nucleus accumbens neurotransmission and effort-related choice behavior in food motivation: effects of drugs acting on dopamine, adenosine, and muscarinic acetylcholine receptors. Neurosci Biobehav Rev (2013) 0.93

Translational Rodent Paradigms to Investigate Neuromechanisms Underlying Behaviors Relevant to Amotivation and Altered Reward Processing in Schizophrenia. Schizophr Bull (2015) 0.93

A meta-analysis of profile and time-course of symptom change in acute schizophrenia treated with atypical antipsychotics. Int J Neuropsychopharmacol (2005) 0.93

Historical development of the dopamine hypothesis of schizophrenia. J Hist Neurosci (2002) 0.92

Effects of contextual processing on visual conditional associative learning in schizophrenia. Biol Psychiatry (2000) 0.92

Conditional associative learning in drug-free schizophrenic patients. Neuropsychobiology (1987) 0.91

Amotivation and functional outcomes in early schizophrenia. Psychiatry Res (2013) 0.91

Treatment resistant schizophrenia and response to antipsychotics: a review. Schizophr Res (2011) 0.90

Modeling motivational deficits in mouse models of schizophrenia: behavior analysis as a guide for neuroscience. Behav Processes (2011) 0.89

Endocannabinoid-dopamine interactions in striatal synaptic plasticity. Front Pharmacol (2012) 0.85

The effects of pharmacological modulation of the serotonin 2C receptor on goal-directed behavior in mice. Psychopharmacology (Berl) (2015) 0.84

Treatment of negative and cognitive symptoms. Curr Psychiatry Rep (1999) 0.83

Increased dopamine D2 receptor activity in the striatum alters the firing pattern of dopamine neurons in the ventral tegmental area. Proc Natl Acad Sci U S A (2015) 0.81

Effort Cost Computation in Schizophrenia: A Commentary on the Recent Literature. Biol Psychiatry (2015) 0.80

The Role of Motivation in Cognitive Remediation for People with Schizophrenia. Curr Top Behav Neurosci (2016) 0.79